ChemoCentryx
CCXI
#3542
Rank
โ‚ฌ3.25 B
Marketcap
45,27ย โ‚ฌ
Share price
0.00%
Change (1 day)
26.75%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -โ‚ฌ0.12 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are โ‚ฌ37.2 Million. In 2021 the company made an earning of -โ‚ฌ0.12 Billion a decrease over its 2020 earnings that were of -โ‚ฌ45.9 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ0.12 Billion4.91%
2021 -โ‚ฌ0.12 Billion144.84%
2020 -โ‚ฌ45.9 Million-1.18%
2019 -โ‚ฌ46.45 Million45.17%
2018 -โ‚ฌ32 Million-305.69%
2017 โ‚ฌ15.55 M-144.7%
2016 -โ‚ฌ34.8 Million-15.52%
2015 -โ‚ฌ41.19 Million0.85%
2014 -โ‚ฌ40.85 Million21.47%
2013 -โ‚ฌ33.63 Million-1.24%
2012 -โ‚ฌ34.05 Million906.88%
2011 -โ‚ฌ3.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.20 B-24,905.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.31 B-9,175.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.44 B-1,371.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.17 B-6,412.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.65 B-1,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ20.10 B-17,779.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.99 B-6,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.11 B-7,238.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.87 B-1,747.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel